3-Benzyl-5-((3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one

Catalog No. :
ACQAFP187
CAS No. :
623936-11-8
Molecular Formula :
C27H20FN3OS2
Molecular Weight :
485.61

IUPAC Name:(Z)-3-benzyl-5-((3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one

3-Benzyl-5-((3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Benzyl-5-((3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one
IUPAC Name(Z)-3-benzyl-5-((3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one
Molecular FormulaC27H20FN3OS2
Molecular Weight485.61
SMILESO=C1N(CC2=CC=CC=C2)C(S/C1=C\C3=CN(C4=CC=CC=C4)N=C3C5=CC=C(C)C(F)=C5)=S
InChI KeySFGYCLWTSBZHDZ-IWIPYMOSSA-N
SynonymSALOR-INT L438812-1EA;(5Z)-3-BENZYL-5-([3-(3-FLUORO-4-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE)-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 5-[[3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylene]-3-(phenylmethyl)-2-thioxo-
CAS No.623936-11-8

Synthetic Route by SureRoute

1. ACQAFP187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMSTW147 route compound structure diagram
    ACMSTW14710574-69-3 In Stock
  4. Then
  5. ACQAFP187 route product structure diagram
    ACQAFP187623936-11-8
Inquiry

2. ACQAFP187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQAFP187 route product structure diagram
    ACQAFP187623936-11-8
Inquiry

Comments (0)